Clinical characteristics | |
---|---|
Diagnosis at admission | avian influenza A(H7N9),ARDS,Sepsis,Septic shock |
H7N9-RNA (BLF&pharynx swab) | From March 13th to March 29th:positive |
Acinetobacter Baumannii | From March 17 to March 25:positive |
Respiratory support (outer court) | Time from symptoms onset to NIV (15 days); |
Time from NIV to MV initiation (1 day); | |
Time from MV initiation to VV-ECMO initiation (2 days) | |
Respiratory support (our hospital) | March 13 to 19:VV-ECMO duration |
March 13 to April 6:MV | |
April 6 to 9:high flow oxygen through trachea cannula,oxygen flow rate:50 ~ 55 L/min | |
April 9 to 14:high flow oxygen through face mask,oxygen flow rate:35 ~ 40 L/min | |
April 14 to 17:administering oxygen inhalation through nasal catheter,oxygen flow rate:2-6 L/min | |
April 17 to 20:stop oxygen inhalation | |
Antiviral therapy | March 13 to April 1:Oseltamivir 150 mg,Bid |
Anti infection treatments | March 13 to April 16:Tienam 1.0 g,Tid;Tigecycline 50 mg,Bid;Moxifloxacin 400 mg,Qd.etc. Adjust medication according to the results of culture and drug sensitivity. |
Antifungal therapy | March 13 to April 11:Micafungin 50 mg,Qd. |
steroid therapy | March 13 to April 11:methylprednisolon 80 mg,Bid,gradually reduced dosage. |